Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Limosilactobacillus reuteri subsp. kinnaridis strain:BG-R46

ABSTRACT: Limosilactobacillus reuteri subsp. kinnaridis strain:BG-R46 (DSM 32846) Genome sequencing

PROVIDER: PRJNA1153400 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Proteomic analysis of Limosilactobacillus reuteri DSM 17938

Project description:The aim of this work was to assess the antibiofilm activity of Cell Free Supernatant (CFS) produced by Limosilactobacillus reuteri DSM 17938 versus biofilm-producer bacterial species of clinical relevance.

2025-06-09 | PXD035326 | Pride

Limosilactobacillus reuteri strain:BG-R33 (DSM 33633)

Project description:Limosilactobacillus reuteri strain:BG-R33 (DSM 33633) Genome sequencing

| PRJNA1138931 | ENA

Limosilactobacillus reuteri subsp. reuteri strain:DSM 20016

Project description:Limosilactobacillus reuteri subsp. reuteri strain:DSM 20016 Raw sequence reads

| PRJNA297938 | ENA

Limosilactobacillus reuteri subsp. kinnaridis strain:DSM 17938

Project description:Limosilactobacillus reuteri subsp. kinnaridis strain:DSM 17938 Genome sequencing

| PRJNA1153401 | ENA

Expression of stress responsive genes enables Limosilactobacillus reuteri

Project description:Expression of stress responsive genes enables Limosilactobacillus reuteri to cross-protection against acid, bile salt and freeze-drying

2023-11-03 | PXD046687 |

RNA-seq analysis on the liver of darkness rats treated with Limosilactobacillus reuteri

Project description:We have previously demonstrated that the arrhythmic expressions of circadian clock genes due to constant darkness induce glycometabolic and reproductive hallmarks of polycystic ovary syndrome (PCOS) in rats. Limosilactobacillus reuteri (L.reuteri) is a promising dietary intervention for host dysmetabolism, while its potential effect on circadian dysrhythmia-induced PCOS remains elusive. Here, we evaluated the amelioration of L.reuteri regimen on constant darkness-induced PCOS-like rats through detecting hepatic gene expression profiles by RNA-seq.

2023-07-11 | GSE169501 | GEO

Limosilactobacillus reuteri-derived exopolysaccharides facilitate the repair of intestinal epithelium barrier compromised by chemotherapy exposure

Project description:A majority of patients undergoing chemotherapy treatment develop side effects that delay further cancer treatment. Antimetabolites, like 5 Fluorouracil (5 FU), are known to induce gut and oral inflammation, highlighting the importance of chemotherapy toxicity management. Here, we aimed to study whether probiotic bacterium Limosilactobacillus reuteri DSM 17938 (LR)-secreted components, including cell-free supernatant (CFS), exopolysaccharides (EPS), and extracellular membrane vesicles (MV), can improve gut barrier integrity following 5 FU exposure. Collectively, 5 FU altered the viability, metabolic activity, barrier integrity, and functional response of Caco-2 cells. EPS stimulation after 5 FU removal significantly improved the integrity and permeability of intestinal barrier through modulation of the transcriptional program associated with extracellular matrix and structure organization. Further, we found that CFS, MV and EPS differentially influenced monocyte polarization pathways, when monocytes were cultured with the supernatant from 5 FU exposed Caco-2 cells. Together, our findings suggest that the incorporation of bacterial metabolites, such as EPS, during chemotherapy could accelerate intestinal barrier recovery without suppressing the immune system, potentially allowing for a more effective scheduling of therapy in cancer patients.

2026-04-17 | GSE288972 | GEO

Limosilactobacillus reuteri

Project description:Limosilactobacillus reuteri Genome sequencing

| PRJNA994435 | ENA

Limosilactobacillus reuteri

Project description:Limosilactobacillus reuteri Genome sequencing

| PRJNA995515 | ENA

Limosilactobacillus reuteri

Project description:Limosilactobacillus reuteri Genome sequencing

| PRJNA1212859 | ENA